|
Volumn 51, Issue 5, 2013, Pages 357-366
|
Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection
|
Author keywords
MRSA infection; Pharmacodynamics; Pharmacokinetics; Teicoplanin
|
Indexed keywords
C REACTIVE PROTEIN;
CREATININE;
SERUM ALBUMIN;
TEICOPLANIN;
ABSENCE OF SIDE EFFECTS;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL ASSESSMENT;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CREATININE CLEARANCE;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG DOSE REGIMEN;
FEMALE;
HUMAN;
JAPANESE;
LEUKOCYTE COUNT;
LIMIT OF DETECTION;
LOADING DRUG DOSE;
MAJOR CLINICAL STUDY;
MALE;
MAXIMUM PLASMA CONCENTRATION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION;
MINIMUM INHIBITORY CONCENTRATION;
PROTEIN BLOOD LEVEL;
TEMPERATURE MEASUREMENT;
ADULT;
AGED;
ANTI-BACTERIAL AGENTS;
ASIAN CONTINENTAL ANCESTRY GROUP;
BIOLOGICAL MARKERS;
COMPUTER SIMULATION;
CREATININE;
DRUG ADMINISTRATION SCHEDULE;
DRUG MONITORING;
FEMALE;
GLOMERULAR FILTRATION RATE;
HUMANS;
JAPAN;
MALE;
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;
MICROBIAL SENSITIVITY TESTS;
MIDDLE AGED;
MODELS, BIOLOGICAL;
MODELS, STATISTICAL;
MONTE CARLO METHOD;
PROTEIN BINDING;
RETROSPECTIVE STUDIES;
SERUM ALBUMIN;
STAPHYLOCOCCAL INFECTIONS;
TEICOPLANIN;
TREATMENT OUTCOME;
|
EID: 84878048553
PISSN: 09461965
EISSN: None
Source Type: Journal
DOI: 10.5414/CP201739 Document Type: Article |
Times cited : (32)
|
References (10)
|